RFK Jr. is moving to temporarily allow six experimental peptides to be sold by compounding pharmacies even though FDA scientists have warned that their safety and benefits remain unproven.
RFK Jr. is moving to temporarily allow six experimental peptides to be sold by compounding pharmacies even though FDA scientists have warned that their safety and benefits remain unproven.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in